Trials / Completed
CompletedNCT01502631
Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury (ASCI)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SUN13837 Injection in Adult Subjects With Acute Spinal Cord Injury
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Daiichi Sankyo · Industry
- Sex
- All
- Age
- 16 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to gather scientific information about the effectiveness of the study drug, SUN13837 Injection, when compared with the placebo (inactive substance) in participants with acute spinal cord injury.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | SUN13837 injection | SUN13837 injection, injection 1 x daily for 28 doses |
| DRUG | Placebo | Matching placebo, volume equivalent to injection 1 x daily for 28 doses |
Timeline
- Start date
- 2012-08-08
- Primary completion
- 2014-09-21
- Completion
- 2014-09-21
- First posted
- 2012-01-02
- Last updated
- 2021-01-15
- Results posted
- 2021-01-15
Locations
67 sites across 7 countries: United States, Canada, Czechia, France, Poland, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT01502631. Inclusion in this directory is not an endorsement.